CardieX Receives FDA 510(K) Clearance for a World-First Vascular Biometric Monitor
CardieX Limited announced its new arterial health monitor, the CONNEQT Pulse (Pulse), has received 510(k) clearance from the U.S. Food and Drug Administration (FDA).
Latest Press Releases
The 'Press Releases' section offers the latest product-specific and company-related updates to our esteemed clients, providing them with a valuable resource. Members can leverage this platform for quick, efficient, and effective visibility.
— Our press release programs complement our content distribution initiatives, ensuring strong positioning across major media outlets and social media channels. This enhances the visibility of your message within the global pharmaceutical industry.
— Our press release programs complement our content distribution initiatives, ensuring strong positioning across major media outlets and social media channels. This enhances the visibility of your message within the global pharmaceutical industry.
Sai Life Sciences opens SSRL, a dedicated research facility
Sai Life Sciences, one of India's fastest growing global Contract Research, Development & Manufacturing Organisations (CRO-CDMO), announced the opening of Sai Schrödinger Research Laboratories (SSRL).
Bridgewest Group completes acquisition of sterile injectable manufacturing plant
Global private investment firm, Bridgewest Group, recognized for developing innovative companies in life sciences, software, and deep tech, announces that it has completed the acquisition of the Perth sterile injectable manufacturing facility from Pfizer (Perth) Pty Ltd, a subsidiary of Pfizer, Inc.
Sintetica US launches Lidocaine Hydrochloride Injection
Sintetica S.A., an international pharmaceutical company with manufacturing facilities in Switzerland, announces the launch of Lidocaine Hydrochloride Injection, USP 1%, 2% and 4% through its subsidiary Sintetica US.
Dr. Anton Jorgensen begins lumbar total Joint replacement clinical trial
Anton Jorgensen, MD and Ortho San Antonio has announced the first cases in the BalancedBack Total Joint Replacement pivotal clinical trial using the breakthrough 3Spine MOTUS device, as an alternative to lumbar spinal fusion surgery. Dr. Jorgensen completed the surgeries at the Foundation Surgical Hospital of San Antonio.
Nexus Pharmaceuticals, Receives EMERPHED® (ephedrine sulfate injection) Pre-Filled Syringe
Nexus Pharmaceuticals, Inc. has announced that it has received US Food and Drug Administration (FDA) approval for EMERPHED® (ephedrine sulfate injection) in 25mg/5mL and 50mg/10mL single-dose pre-filled syringes. The 10mL presentation is the first and only FDA-approved ready-to-administer 10mL pre-filled syringe available.
Stimufend® pegfilgrastim-fpgk Now Available in the United States
Fresenius Kabi had announced the immediate availability in the U.S. of Stimufend® (pegfilgrastim-fpgk), the company’s biosimilar to Neulasta® (pegfilgrastim), for use in patients at risk for febrile neutropenia, a common side effect of many anti-cancer medications. Stimufend is available in a single-dose, pre-filled syringe that delivers 6mg/0.6mL solution for subcutaneous injection.
Syqe Medical Announces Agreement with Israeli Ministry of Defence
Syqe Medical, the developer of innovative technologies in the world of medical devices, is pleased to announce the signing of an agreement with the Israeli Ministry of Defence to supply the SyqeAir Inhaler and Cartridges to all veterans prescribed medical cannabis by inhalation through the company's ground-breaking platform.
PureTech to Advance LYT-300 Oral Allopregnanolone
PureTech Health plc a clinical-stage biotherapeutics company dedicated to changing the treatment paradigm for devastating diseases, had announced that it will advance LYT-300 (oral allopregnanolone) for the potential treatment of anxiety disorders and postpartum depression (PPD).
Synthetic DNA Manufacturing Factory of the Future
Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform.